Biological critical mineral recovery is emerging fast — but industry still has no trusted framework for comparing those biological pathways before committing capital, pilots, procurement or supplier relationships. Bioseq is that framework.
Bioseq provides route-selection intelligence for biological critical mineral recovery: a structured, evidence-graded way to evaluate which biological pathways exist for a given element and stream, how strong the evidence behind each one is, what conditions it needs, where the validation gaps lie, and whether it is ready for concept-stage review, pilot testing, or exclusion. It is a decision framework — not a process, not a product, and not a speculative organism play.
Biology can recover minerals — that much is established. The harder question is whether a buyer can compare biological routes with enough confidence to make a decision. Today they cannot. The relevant evidence is scattered across academic literature, biological databases, isolated pilot work and supplier claims, each using different conditions, units and standards of proof.
Thousands of papers, strain databases, conference abstracts, pilot reports and vendor datasheets — none designed to be compared with one another. A result proven in a warm marine system tells a buyer almost nothing about a cold, acidic waste stream, yet both surface in the same literature search with no signal of which is decision-grade.
The issue is not simply whether biology works. It is that an investor, programme or industrial buyer cannot see, at a glance, which pathway is supported by direct evidence, which rests on analogy, and which is unproven. Without that, biological routes get excluded by default — or funded on optimism rather than evidence.
Before funding a pilot, altering a process, or committing to a supplier, an organisation needs to know which biological pathways even exist for its target element and stream — and then how to rank them. Route-selection intelligence answers the questions that come before the pilot, where the cost of being wrong is highest and the available information is weakest.
Which biological pathways exist for this element and feed; what evidence supports each; what process conditions they require; what validation gaps remain; and whether each route is suitable for concept-stage review, pilot testing, or exclusion. These are decisions, not literature reviews.
A pilot built around the wrong pathway — a strain that cannot survive the stream, or a claim that does not replicate — consumes capital and calendar before the error surfaces. Route selection moves that judgement forward in time, to where it is cheap to correct.
Bioseq structures biological–mineral interactions into a single, scored intelligence layer. It combines scientific literature, biological data, industrial context, evidence grading and validation feedback — so that every biological route carries a confidence signal an engineer or investor can defend in a technical review.
Bioseq does not mine, process, or produce. That independence is what lets the route-selection intelligence be trusted — each assessment answers to the evidence, not to a supplier's order book.
Every interaction in the layer carries an evidence tier and a design-use status, and every score is traceable to the source studies and conditions behind it. The output is not a claim that "biology might work" — it is a ranked, conditioned, auditable view of which biological routes are worth concept-stage review, which are worth a pilot, and which should be set aside.
Route-selection intelligence is only useful if it is consistent. Bioseq grades every biological pathway against the same structured set of dimensions, so that routes drawn from very different sources can be compared on equal terms.
The specific biological agent — alga, bacterium or consortium — identified and characterised, not described in general terms.
The critical mineral or strategic material the route is being assessed to recover — cobalt, nickel, a rare earth, lithium and beyond.
The biological mechanism in play — biosorption, bioaccumulation, bioleaching or precipitation — and how the element is actually captured.
The operating envelope the route requires: pH range, temperature, salinity and the stream chemistry it can tolerate.
How well the route is supported — direct, replicated, analogous, inferred or simulated. The most conservative supporting evidence sets the tier.
What an engineer may legitimately do with the route in a stage-gate review — from concept mass balance through to exclude, not measured.
Where the route sits on the path from research finding to industrial option — concept, screening, pilot-ready or beyond.
What integrating the route would cost a process to run — reagents, energy, residence time and downstream handling.
The specific evidence that is still missing — the test that would move the route from plausible to proven for this stream.
Route-selection intelligence is built for the organisations that must commit real capital or process change to biological routes — and need to know which ones deserve it.
Several shifts are arriving at once — and together they make a structured way to evaluate biological routes both necessary and, for the first time, possible.
Demand for cobalt, nickel and rare earths is rising sharply while supply remains concentrated. Organisations are actively seeking new and secondary routes — and need to know which biological ones are real.
Interest is turning to recovery from tailings, residues, mine water and recycled streams — exactly the conditions where biological routes can compete, if the right pathway is selected.
Biological processing is shifting from research curiosity to a genuine industrial option — which means buyers now face real route-selection decisions, not just academic questions.
AI-native evidence systems make it possible to structure, grade and compare thousands of biological results at scale — turning a fragmented literature into a decision layer.
If you are evaluating biological routes for critical mineral recovery — and need to know which pathways are credible before committing capital, a pilot or a supplier — we should talk. Speak to Bioseq about route-selection intelligence for biological critical mineral recovery.
Contact Bioseq →